ENTITY

Zhejiang Hisun Pharmaceutical Co, Ltd. (600267 CH)

28
Analysis
Health CareChina
Zhejiang Hisun Pharmaceutical Co. Ltd. develops and manufactures pharmaceutical products. The Company's products include anti-tumor, anti-parasite, cardiovascular, and anti-infection drugs.
more
25 Nov 2024 17:27

The Stocks to Own in China – Vol. 34

We highlight 10 China A stocks that look interesting to us based on our FVMR Methodology. Portfolio changes: Three stocks remain, seven new join...

Share
07 Nov 2024 09:02

What Does a Trump Presidency Mean for China Healthcare?

Trump successfully elected as the US President. His reform in healthcare is to achieve the independence of US pharmaceutical supply chain and...

Logo
451 Views
Share
bearishPfizer Inc
09 Nov 2022 09:02

Pfizer Inc (PFE.US) - What if Pfizer Loses the China Market in the Future?

Pfizer’s China business faces challenges due to VBP/NRDL negotiation and potential further deterioration of Sino-US relations. Together with...

Logo
189 Views
Share
08 Jun 2022 09:19

Geopolitical Conflicts and War: The Impact on China API Industry

Energy/food crisis due to war will increase API cost, creating opportunity for China API. For IPEF/Blinken’s speech, politics is always a tool to...

Logo
261 Views
Share
15 Feb 2022 09:00

Huadong Medicine Co Ltd (000963.CH) - The Medical Cosmetology Business Is the Key Breakthrough Point

We analyzed the logic of performance decline in terms of Huadong's core business.But the entry of medical cosmetology equipment field is a wise...

Logo
246 Views
Share
x